About Index Trending news
Lists
Pricing
Kadmon

Kadmon

Kadmon

Kadmon Corporation is a biopharmaceutical company offering products and servicesfor the treatment and management of hepatitis C.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$80,400,000
RA Capital Management, Vivo Capital, Acuta Capital Partners, +1
Post-IPO equity
$23,000,000
Employees

Team size

50+
Locations
HQ
$23,000,000 Post-IPO equity
businesswire

Kadmon Announces Approximately $23 Million Equity Financing

Xconomy

Kadmon Seeks IPO With Unusual Terms That Benefit Waksal, Debt Holders

Stock markets Strategy